18F-FDG labeling of mesenchymal stem cells and multipotent adult progenitor cells for PET imaging: Effects on ultrastructure and differentiation capacity

Journal of Nuclear Medicine

Volumn 54, Issue 3, 2013, Pages 447-454

  Wolfs, Esther ^a   Struys, Tom ^a,b   Notelaers, Tineke ^c   Roberts, Scott J ^c   Sohni, Abhishek ^c   Bormans, Guy ^c   Van Laere, Koen ^a   Luyten, Frank P ^c   Gheysens, Olivier ^a   Lambrichts, Ivo ^b   Verfaillie, Catherine M ^c   Deroose, Christophe M ^a  

^a DEPARTMENT OF IMAGING AND PATHOLOGY   (Belgium)

^b HASSELT UNIVERSITY   (Belgium)

^c UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

18F FDG; Mesenchymal stem cell; Multipotent adult progenitor cell; Radiotoxicity; PET

Indexed keywords

FLUORODEOXYGLUCOSE F 18; DIAGNOSTIC AGENT; FLUORINE; RADIOPHARMACEUTICAL AGENT;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL COUNT; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SIZE; CELL ULTRASTRUCTURE; CELL VACUOLE; CELL VIABILITY; CONTROLLED STUDY; DRUG CYTOTOXICITY; ISOTOPE LABELING; LYSOSOME; MESENCHYMAL STEM CELL; MITOCHONDRION; MOUSE; MULTIPOTENT ADULT PROGENITOR CELL; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RADIOACTIVITY; RAT; ROUGH ENDOPLASMIC RETICULUM; STEM CELL; TRANSMISSION ELECTRON MICROSCOPY; ADULT STEM CELL; ANIMAL; CELL CULTURE; MESENCHYMAL STROMA CELL; METABOLISM; MULTIPOTENT STEM CELL; REGENERATIVE MEDICINE; SCINTISCANNING; TISSUE ENGINEERING; ULTRASTRUCTURE;

ADULT STEM CELLS; ANIMALS; CELL DIFFERENTIATION; CELLS, CULTURED; FLUORINE RADIOISOTOPES; FLUORODEOXYGLUCOSE F18; MESENCHYMAL STROMAL CELLS; MICE; MICROSCOPY, ELECTRON, TRANSMISSION; MULTIPOTENT STEM CELLS; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; RATS; REGENERATIVE MEDICINE; TISSUE ENGINEERING;

MLCS; MLOWN;

EID: 84874830068     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: 10.2967/jnumed.112.108316     Document Type: Article

References (39)

1. Shanthly N, Aruva MR, Zhang K, Mathew B, Thakur ML. Stem cells: a regenerative pharmaceutical. Q J Nucl Med Mol Imaging. 2006;50:205-216. (Pubitemid 44649660)
2. Weissman IL. Stem cells: units of development, units of regeneration, and units in evolution. Cell. 2000;100:157-168. (Pubitemid 30046304)
3. Friedenstein AJ, Gorskaja JF, Kulagina NN. Fibroblast precursors in normal and irradiated mouse hematopoietic organs. Exp Hematol. 1976;4:267-274.
4. Bosch P, Musgrave DS, Lee JY, et al. Osteoprogenitor cells within skeletal muscle. J Orthop Res. 2000;18:933-944. (Pubitemid 32063039)
5. Boquest AC, Shahdadfar A, Fronsdal K, et al. Isolation and transcription profiling of purified uncultured human stromal stem cells: alteration of gene expression after in vitro cell culture. Mol Biol Cell. 2005;16:1131-1141. (Pubitemid 40349551)
6. Gronthos S, Mankani M, Brahim J, Robey PG, Shi S. Postnatal human dental pulp stem cells (DPSCs) in vitro and in vivo. Proc Natl Acad Sci USA. 2000;97:13625-13630.
7. Caplan AI. Mesenchymal stem cells. J Orthop Res. 1991;9:641-650.
8. Pittenger MF, Mackay AM, Beck SC, et al. Multilineage potential of adult human mesenchymal stem cells. Science. 1999;284:143-147. (Pubitemid 29282067)
9. Uccelli A, Pistoia V, Moretta L. Mesenchymal stem cells: a new strategy for immunosuppression? Trends Immunol. 2007;28:219-226. (Pubitemid 46667240)
10. Jiang Y, Vaessen B, Lenvik T, Blackstad M, Reyes M, Verfaillie CM. Multipotent progenitor cells can be isolated from postnatal murine bone marrow, muscle, and brain. Exp Hematol. 2002;30:896-904. (Pubitemid 34845893)
11. Sohni A, Verfaillie CM. Multipotent adult progenitor cells. Best Pract Res Clin Haematol. 2011;24:3-11.
12. Subramanian K, Geraerts M, Pauwelyn KA, et al. Isolation procedure and characterization of multipotent adult progenitor cells from rat bone marrow. Methods Mol Biol. 2010;636:55-78.
13. Roobrouck VD, Clavel C, Jacobs SA, et al. Differentiation potential of human postnatal mesenchymal stem cells, mesoangioblasts, and multipotent adult progenitor cells reflected in their transcriptome and partially influenced by the culture conditions. Stem Cells. 2011;29:871-882.
14. Petite H, Viateau V, Bensaid W, et al. Tissue-engineered bone regeneration. Nat Biotechnol. 2000;18:959-963. (Pubitemid 32977376)
15. Zhou XZ, Leung VY, Dong QR, Cheung KM, Chan D, Lu WW. Mesenchymal stem cell-based repair of articular cartilage with polyglycolic acid-hydroxyapatite biphasic scaffold. Int J Artif Organs. 2008;31:480-489.
16. Badorff C, Brandes RP, Popp R, et al. Transdifferentiation of blood-derived human adult endothelial progenitor cells into functionally active cardiomyocytes. Circulation. 2003;107:1024-1032. (Pubitemid 36258727)
17. Nakamizo A, Marini F, Amano T, et al. Human bone marrow-derived mesenchymal stem cells in the treatment of gliomas. Cancer Res. 2005;65:3307-3318. (Pubitemid 40524615)
18. Miletic H, Fischer Y, Litwak S, et al. Bystander killing of malignant glioma by bone marrow-derived tumor-infiltrating progenitor cells expressing a suicide gene. Mol Ther. 2007;15:1373-1381. (Pubitemid 46965333)
19. Bengel FM. Noninvasive stem cell tracking. J Nucl Cardiol. 2011;18:966-973.
20. Caracó C, Aloj L, Chen LY, Chou JY, Eckelman WC. Cellular release of [18F]2- fluoro-2-deoxyglucose as a function of the glucose-6-phosphatase enzyme system. J Biol Chem. 2000;275:18489-18494. (Pubitemid 30414809)
21. Prince HM, Wall DM, Ritchie D, et al. In vivo tracking of dendritic cells in patients with multiple myeloma. J Immunother. 2008;31:166-179.
22. 18F-FDG-labeled peripheral hematopoietic stem cells after intracoronary administration in patients with myocardial infarction. J Nucl Med. 2006;47:1295-1301.
23. Hofmann M, Wollert KC, Meyer GP, et al. Monitoring of bone marrow cell homing into the infarcted human myocardium. Circulation. 2005;111:2198- 2202. (Pubitemid 40632435)
24. Vidal MA, Kilroy GE, Johnson JR, Lopez MJ, Moore RM, Gimble JM. Cell growth characteristics and differentiation frequency of adherent equine bone marrow-derived mesenchymal stromal cells: adipogenic and osteogenic capacity. Vet Surg. 2006;35:601-610. (Pubitemid 44526659)
25. Bretschneider A, Burns W, Morrison A. "Pop-off" technic: the ultrastructure of paraffin-embedded sections. Am J Clin Pathol. 1981;76:450-453. (Pubitemid 11011294)
26. 18F-FDG-labeled progenitor cell therapy for acute myocardial infarction. J Nucl Med. 2007;48:1708-1714. (Pubitemid 47572719)
27. Melder RJ, Elmaleh D, Brownell AL, Brownell GL, Jain RK. A method for labeling cells for positron emission tomography (PET) studies. J Immunol Methods. 1994;175:79-87. (Pubitemid 24305233)
28. Adonai N, Nguyen KN, Walsh J, et al. Ex vivo cell labeling with 64Cupyruvaldehyde- bis(N4-methylthiosemicarbazone) for imaging cell trafficking in mice with positron-emission tomography. Proc Natl Acad Sci USA. 2002;99:3030-3035. (Pubitemid 34240580)
29. Elhami E, Goertzen AL, Xiang B, et al. Viability and proliferation potential of adipose-derived stem cells following labeling with a positron-emitting radiotracer. Eur J Nucl Med Mol Imaging. 2011;38:1323-1334.
30. Chen MF, Lin CT, Chen WC, et al. The sensitivity of human mesenchymal stem cells to ionizing radiation. Int J Radiat Oncol Biol Phys. 2006;66:244-253.
31. Chan DC. Mitochondrial fusion and fission in mammals. Annu Rev Cell Dev Biol. 2006;22:79-99.
32. Detmer SA, Chan DC. Functions and dysfunctions of mitochondrial dynamics. Nat Rev Mol Cell Biol. 2007;8:870-879. (Pubitemid 47622562)
33. Ron D, Walter P. Signal integration in the endoplasmic reticulum unfolded protein response. Nat Rev Mol Cell Biol. 2007;8:519-529. (Pubitemid 46985379)
34. Daly MJ. Death by protein damage in irradiated cells. DNA Repair (Amst). 2012;11:12-21.
35. Brenner W, Aicher A, Eckey T, et al. 111In-labeled CD341 hematopoietic progenitor cells in a rat myocardial infarction model. J Nucl Med. 2004;45:512-518. (Pubitemid 47618629)
36. Aicher A, Brenner W, Zuhayra M, et al. Assessment of the tissue distribution of transplanted human endothelial progenitor cells by radioactive labeling. Circulation. 2003;107:2134-2139. (Pubitemid 36532196)
37. Park BN, Shim W, Lee G, et al. Early distribution of intravenously injected mesenchymal stem cells in rats with acute brain trauma evaluated by 99mTc-HMPAO labeling. Nucl Med Biol. 2011;38:1175-1182.
38. Detante O, Moisan A, Dimastromatteo J, et al. Intravenous administration of 99mTc-HMPAO-labeled human mesenchymal stem cells after stroke: in vivo imaging and biodistribution. Cell Transplant. 2009;18:1369-1379.
39. Toyama H, Ichise M, Liow JS, et al. Evaluation of anesthesia effects on [18F] FDG uptake in mouse brain and heart using small animal PET. Nucl Med Biol. 2004;31:251-256. (Pubitemid 38315120)